ARCHIVES

In Brief: Norman Sharpless Named Director of UNC Lineberger

This article is from The Cancer Letter archive.

Vol. 39 No. 33 | September 6, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Leave Blair, Landlow Building; House To Hold Hearings March 5 On NCI’s 1998 Budget

February 13, 1987

ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies

May 2, 2003

ASCO, ASH Issue Guidelines On Use Of Epo For Anemia

October 25, 2002

NCI CTEP Approved Trials For the Month of September

September 27, 2013

OMB Cut $150 Million From NCI Request

March 22, 1974

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995